Literature DB >> 2460564

Fluorescent staining for leukocyte chemotaxis. Eosinophil-specific fluorescence with aniline blue.

E L McCrone1, D R Lucey, P F Weller.   

Abstract

To overcome problems associated with the quantitation of human eosinophil chemotaxis in micropore filters, we have developed a fluorescent method of specifically staining eosinophils in chemotactic filters. A neutral solution of aniline blue yielded bright green fluorescent staining of the cytoplasmic granules of eosinophils. Other leukocytes and contaminating neutrophils potentially present with eosinophils did not fluoresce with aniline blue. The fluorescent staining eosinophils within filters provided bright, non-fading images that facilitated visual microscopic counting and were of sufficiently high contrast, unlike those with conventional eosinophil stains, to allow image analyzer based enumeration of eosinophil chemotactic responses at levels through the filters. Although not cell type-specific, congo red and ethidium bromide also provided high contrast, fluorescent images of all leukocyte types within chemotactic filters. Fluorescent staining with aniline blue constitutes a rapid, stable and eosinophil-specific stain that facilitates the visual or image analyzer-based quantitation of eosinophil chemotaxis.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2460564     DOI: 10.1016/0022-1759(88)90157-3

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  10 in total

1.  The eosinophil as a cellular source of transforming growth factor alpha in healing cutaneous wounds.

Authors:  R Todd; B R Donoff; T Chiang; M Y Chou; A Elovic; G T Gallagher; D T Wong
Journal:  Am J Pathol       Date:  1991-06       Impact factor: 4.307

2.  Production of transforming growth factor alpha by hamster eosinophils.

Authors:  A Elovic; S J Galli; P F Weller; A L Chang; T Chiang; M Y Chou; R B Donoff; G T Gallagher; K Matossian; J McBride
Journal:  Am J Pathol       Date:  1990-12       Impact factor: 4.307

3.  Sequential expression of transforming growth factors alpha and beta 1 by eosinophils during cutaneous wound healing in the hamster.

Authors:  D T Wong; R B Donoff; J Yang; B Z Song; K Matossian; N Nagura; A Elovic; J McBride; G Gallagher; R Todd
Journal:  Am J Pathol       Date:  1993-07       Impact factor: 4.307

4.  Human eosinophil adherence to vascular endothelium mediated by binding to vascular cell adhesion molecule 1 and endothelial leukocyte adhesion molecule 1.

Authors:  P F Weller; T H Rand; S E Goelz; G Chi-Rosso; R R Lobb
Journal:  Proc Natl Acad Sci U S A       Date:  1991-08-15       Impact factor: 11.205

5.  Human eosinophils express functional interleukin 2 receptors.

Authors:  T H Rand; D S Silberstein; H Kornfeld; P F Weller
Journal:  J Clin Invest       Date:  1991-09       Impact factor: 14.808

6.  Identification of rabbit eosinophils and heterophils in cutaneous healing wounds.

Authors:  B Z Song; R B Donoff; T Tsuji; R Todd; G T Gallagher; D T Wong
Journal:  Histochem J       Date:  1993-10

7.  Human eosinophils can express the cytokines tumor necrosis factor-alpha and macrophage inflammatory protein-1 alpha.

Authors:  J J Costa; K Matossian; M B Resnick; W J Beil; D T Wong; J R Gordon; A M Dvorak; P F Weller; S J Galli
Journal:  J Clin Invest       Date:  1993-06       Impact factor: 14.808

8.  Human eosinophils express transforming growth factor alpha.

Authors:  D T Wong; P F Weller; S J Galli; A Elovic; T H Rand; G T Gallagher; T Chiang; M Y Chou; K Matossian; J McBride
Journal:  J Exp Med       Date:  1990-09-01       Impact factor: 14.307

9.  CD4-mediated stimulation of human eosinophils: lymphocyte chemoattractant factor and other CD4-binding ligands elicit eosinophil migration.

Authors:  T H Rand; W W Cruikshank; D M Center; P F Weller
Journal:  J Exp Med       Date:  1991-06-01       Impact factor: 14.307

10.  Transforming growth factor beta abrogates the effects of hematopoietins on eosinophils and induces their apoptosis.

Authors:  R Alam; P Forsythe; S Stafford; Y Fukuda
Journal:  J Exp Med       Date:  1994-03-01       Impact factor: 14.307

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.